Precision Medicine for Cardiovascular Disease Prevention: From Where Did We Come, Where Are We Now, and Where Are We Going?

Needs Statement

Physicians, residents, fellows, scientists, and other health professionals in general practice specialties such as internal medicine, oncology, surgery, and pathology need to be updated about the practice and implementation of precision medicine initiatives to improve the delivery of targeted and individualized care. Health professionals should be aware of the ethical issues that arise in the practice of precision medicine. Testing for genetically influenced diseases can affect personalized management of individuals and their families.

Target Audience

Physicians, residents, fellows, medical students, nurses and other health professionals.

Learning Objectives

At the conclusion of the session, the participants should be able to:

  • Explain the current approach to and the role of risk assessment to guide intensity of lifestyle interventions and pharmacotherapy in cardiovascular disease (CVD) prevention.

  • Summarize the genetic testing available and its current role in CVD prevention.

  • Demonstrate a conceptual framework for addressing residual CVD risk with a focus on triglycerides and inflammation.

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
Course expires: 

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or register to take this course.